vs
Beta Bionics, Inc.（BBNX）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是Beta Bionics, Inc.的1.2倍（$32.3M vs $27.6M），RBB Bancorp净利率更高（31.5% vs -79.3%，领先110.7%），Beta Bionics, Inc.同比增速更快（56.6% vs 12.6%）
Beta Bionics是一家专注于糖尿病管理领域的医疗科技企业，核心产品为iLet仿生胰腺，这款可穿戴设备可自动调节胰岛素与胰高血糖素的输送，服务1型和2型糖尿病患者，目前主要面向美国医疗市场，正规划推进全球业务布局。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
BBNX vs RBB — 直观对比
营收规模更大
RBB
是对方的1.2倍
$27.6M
营收增速更快
BBNX
高出44.0%
12.6%
净利率更高
RBB
高出110.7%
-79.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $27.6M | $32.3M |
| 净利润 | $-21.9M | $10.2M |
| 毛利率 | 59.5% | — |
| 营业利润率 | -47.4% | 39.5% |
| 净利率 | -79.3% | 31.5% |
| 营收同比 | 56.6% | 12.6% |
| 净利润同比 | 23.6% | 132.1% |
| 每股收益（稀释后） | $-0.49 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBNXRBB
| Q1 26 | $27.6M | — | ||
| Q4 25 | $32.1M | $32.3M | ||
| Q3 25 | $27.3M | $32.6M | ||
| Q2 25 | $23.2M | $35.8M | ||
| Q1 25 | $17.6M | $28.5M | ||
| Q4 24 | — | $28.7M | ||
| Q3 24 | — | $30.3M | ||
| Q2 24 | — | $27.5M |
净利润BBNXRBB
| Q1 26 | $-21.9M | — | ||
| Q4 25 | $-13.5M | $10.2M | ||
| Q3 25 | $-14.2M | $10.1M | ||
| Q2 25 | $-16.9M | $9.3M | ||
| Q1 25 | $-28.7M | $2.3M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $7.2M |
毛利率BBNXRBB
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.0% | — | ||
| Q3 25 | 55.5% | — | ||
| Q2 25 | 53.8% | — | ||
| Q1 25 | 50.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率BBNXRBB
| Q1 26 | -47.4% | — | ||
| Q4 25 | -50.2% | 39.5% | ||
| Q3 25 | -62.5% | 40.7% | ||
| Q2 25 | -85.5% | 36.1% | ||
| Q1 25 | -105.7% | 11.2% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | — | 31.6% | ||
| Q2 24 | — | 35.6% |
净利率BBNXRBB
| Q1 26 | -79.3% | — | ||
| Q4 25 | -41.9% | 31.5% | ||
| Q3 25 | -52.1% | 31.2% | ||
| Q2 25 | -72.6% | 26.1% | ||
| Q1 25 | -162.5% | 8.0% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | — | 23.1% | ||
| Q2 24 | — | 26.4% |
每股收益（稀释后）BBNXRBB
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-0.16 | $0.59 | ||
| Q3 25 | $-0.33 | $0.59 | ||
| Q2 25 | $-0.39 | $0.52 | ||
| Q1 25 | $-0.93 | $0.13 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | — | $0.39 | ||
| Q2 24 | — | $0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.5M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $271.2M | $523.4M |
| 总资产 | $304.4M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资BBNXRBB
| Q1 26 | $199.5M | — | ||
| Q4 25 | $219.1M | $212.3M | ||
| Q3 25 | $228.7M | $234.9M | ||
| Q2 25 | $249.7M | $191.9M | ||
| Q1 25 | $231.5M | $238.8M | ||
| Q4 24 | — | $257.7M | ||
| Q3 24 | — | $349.4M | ||
| Q2 24 | — | $252.8M |
总债务BBNXRBB
| Q1 26 | — | — | ||
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M |
股东权益BBNXRBB
| Q1 26 | $271.2M | — | ||
| Q4 25 | $287.6M | $523.4M | ||
| Q3 25 | $294.8M | $514.3M | ||
| Q2 25 | $301.6M | $517.7M | ||
| Q1 25 | $313.8M | $510.3M | ||
| Q4 24 | — | $507.9M | ||
| Q3 24 | — | $509.7M | ||
| Q2 24 | — | $511.3M |
总资产BBNXRBB
| Q1 26 | $304.4M | — | ||
| Q4 25 | $328.7M | $4.2B | ||
| Q3 25 | $330.0M | $4.2B | ||
| Q2 25 | $330.0M | $4.1B | ||
| Q1 25 | $338.0M | $4.0B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $3.9B |
负债/权益比BBNXRBB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $43.4M |
| 自由现金流经营现金流 - 资本支出 | — | $42.6M |
| 自由现金流率自由现金流/营收 | — | 131.8% |
| 资本支出强度资本支出/营收 | — | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | — | $73.5M |
8季度趋势，按日历期对齐
经营现金流BBNXRBB
| Q1 26 | — | — | ||
| Q4 25 | $-8.6M | $43.4M | ||
| Q3 25 | $-8.7M | $2.1M | ||
| Q2 25 | $-13.6M | $21.7M | ||
| Q1 25 | $-20.0M | $7.8M | ||
| Q4 24 | — | $58.5M | ||
| Q3 24 | — | $24.5M | ||
| Q2 24 | — | $11.7M |
自由现金流BBNXRBB
| Q1 26 | — | — | ||
| Q4 25 | $-10.5M | $42.6M | ||
| Q3 25 | $-10.0M | $1.8M | ||
| Q2 25 | $-15.4M | $21.6M | ||
| Q1 25 | $-20.3M | $7.6M | ||
| Q4 24 | — | $57.7M | ||
| Q3 24 | — | $24.2M | ||
| Q2 24 | — | $11.5M |
自由现金流率BBNXRBB
| Q1 26 | — | — | ||
| Q4 25 | -32.8% | 131.8% | ||
| Q3 25 | -36.7% | 5.4% | ||
| Q2 25 | -66.2% | 60.2% | ||
| Q1 25 | -115.1% | 26.7% | ||
| Q4 24 | — | 201.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 42.0% |
资本支出强度BBNXRBB
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | 2.5% | ||
| Q3 25 | 4.7% | 1.1% | ||
| Q2 25 | 7.7% | 0.3% | ||
| Q1 25 | 1.9% | 0.6% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.5% |
现金转化率BBNXRBB
| Q1 26 | — | — | ||
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
